Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease

Singapore Medical Journal

Volumn 47, Issue 9, 2006, Pages 780-784

  Sittiwangkul, Rekwan ^a   Pongprot, Y ^a   Silvilairat, S ^a   Phornphutkul, C ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Coronary artery lesion; Gammaglobulin refractory Kawasaki disease; Gammaglobulin resistance; Intravenous immunoglobulin therapy; Kawasaki disease; Methylprednisolone pulse therapy

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; RECURRENT FEVER; RISK FACTOR; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; DRUG RESISTANCE; FEMALE; GAMMA-GLOBULINS; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33748612956     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2:1055-8.
2. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki Syndrome. N Engl J Med 1991; 324:1633-9.
3. Comment in: N Engl J Med 1991; 324:1644-6.
4. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawaski Syndrome Study Group. Pediatr Infect Dis J 1998; 17:1144-8.
5. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000; 105:e78.
6. Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose gammaglobulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000; 137:172-6.
7. Comment in: J Pediatr 2000; 137:149-52.
8. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128:146-9.
9. Comment in: J Pediatr 1996; 129:483-5.
10. Raman V, Kim J, Sharkey A, Chatila T. Response of refractory Kawasaki disease to pulse steroid and cyclosporine A therapy. Pediatr Infect Dis J 2001; 20:635-7.
11. Newburger JW, Takahashi M, Gerber M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever. Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114:1708-33.
12. Erratum in: Pediatrics 2005; 115:1118.
13. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43:211-7.
14. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979; 63:175-9.
15. Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005; 146:622-7.
16. de Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133:254-8.
17. Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994; 89:916-22.
18. Sittiwangkul R, Pongprot Y. Large pleural effusion: an unusual manifestation of Kawasaki disease. Clin Pediatr (Phila) 2004; 43:389-91.
19. Miura M, Ohki H, Tsuchihashi T, et al. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin. Arch Dis Child 2004; 89:776-80.
20. Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 2000; 137:723-6.